These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 13775313)

  • 1. Data on the combined action of insulin and hypoglycaemic sulphonylurea.
    TARDOS L; ERDELY I
    Acta Physiol Acad Sci Hung; 1961; 19():297-303. PubMed ID: 13775313
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of the hypoglycaemic sulphonylurea gliquidone. III. Conformational analysis.
    Lins L; Brasseur R; Malaisse WJ
    Pharmacol Res; 1996; 34(1-2):9-10. PubMed ID: 8981549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels].
    Larsson O; Kindmark H; Bränström R; Berggren PO
    Lakartidningen; 1997 Nov; 94(48):4473-7. PubMed ID: 9424548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHARMACOLOGY AND MODE OF ACTION OF THE HYPOGLYCAEMIC SULPHONYLUREAS AND DIGUANIDES.
    DUNCAN LJ; CLARKE BF
    Annu Rev Pharmacol; 1965; 5():151-62. PubMed ID: 14287878
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of certain sulphonylurea drugs on pantothenic acid metabolism in the rat.
    MIDDLETON EJ; MCLAUGHLAN JM
    Can J Biochem Physiol; 1961 May; 39():837-42. PubMed ID: 13770374
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of sulphonylurea drugs on pantothenic acid metabolism in Tetrahymena pyriformis.
    SHENOY KG; McLAUGHLAN JM
    Can J Biochem Physiol; 1959 Nov; 37():1388-9. PubMed ID: 14445820
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.
    PFEIFFER EF; PFEIFFER M; DITSCHUNEIT H; AHN CS
    Ann N Y Acad Sci; 1959 Sep; 82():479-95. PubMed ID: 14432532
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy and hazards of an experimental hypoglycemic sulfonylurea compound: metahexamide].
    VERNET A; RILLIET B
    Praxis; 1960 Jun; 49():620-3. PubMed ID: 13841881
    [No Abstract]   [Full Text] [Related]  

  • 9. Disulfiramlike actions produced by hypoglycemic sulfonylurea compounds.
    TRUITT EB; DURITZ G; MORGAN AM; PROUTY RW
    Q J Stud Alcohol; 1962 Jun; 23():197-207. PubMed ID: 13922688
    [No Abstract]   [Full Text] [Related]  

  • 10. [The chemotherapeutic use of antidiabetics. Sulfonylurea compounds and glinides].
    Mark M
    Pharm Unserer Zeit; 2002; 31(3):252-62. PubMed ID: 12071122
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative pharmacology of the sulfonylureas.
    RADDING RS; KERN LR; OWENS JC
    Metabolism; 1962 Apr; 11():411-5. PubMed ID: 14489728
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative effects of glucose, sulfonylureas, salicylate, and indole-3-acetic acid on the secretion of insulin activity into pancreatic venous blood.
    SELTZER HS
    J Clin Invest; 1962 Feb; 41(2):289-300. PubMed ID: 13910496
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the problem of the protective effect of sulfonylurea derivatives on the liver].
    KNICK B; RUCKES J
    Verh Dtsch Ges Inn Med; 1959; 65():709-12. PubMed ID: 14410106
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of hypoglycemizing sulfonylureas on the phosphatase activity of the blood].
    da CRUZ
    C R Seances Soc Biol Fil; 1960; 154():229-31. PubMed ID: 13813101
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.
    Cai Z; Lansdell KA; Sheppard DN
    Br J Pharmacol; 1999 Sep; 128(1):108-18. PubMed ID: 10498841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of sulfonylurea on proliferating connective tissue in the liver].
    PETZOLD H; STOEHR K
    Verh Dtsch Ges Inn Med; 1959; 65():455-9. PubMed ID: 14432454
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of long-term sulfonylurea treatment on the haematopoietic system of diabetic patients.
    JAKOBSON T
    Ann Med Intern Fenn; 1961; 50():83-93. PubMed ID: 13789246
    [No Abstract]   [Full Text] [Related]  

  • 18. A new high potency antidiabetic sulfonylurea [N-(1-hexahydro-1-azepinyl)-N'-p-tolyl-sulfonylurea].
    DULIN WE; OSTER HL; McMAHON FG
    Proc Soc Exp Biol Med; 1961 Jun; 107():245-8. PubMed ID: 13724915
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and relative hypoglycemic potencies of four sulfonylureas in man.
    WEST KM; JOHNSON PC
    Diabetes; 1960; 9():454-8. PubMed ID: 13784586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.